Published in Sci Rep on June 21, 2017
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med (2005) 21.56
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med (1998) 14.40
Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature (2005) 5.50
Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates. J Histochem Cytochem (1999) 4.71
EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol (2013) 4.46
Resistance to direct antiviral agents in patients with hepatitis C virus infection. Gastroenterology (2009) 3.89
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A (1996) 3.25
New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology (2014) 3.14
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol (1998) 2.71
Hepatitis C and liver transplantation. Nature (2005) 2.53
Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C. Gut (2014) 2.33
Cell culture and infection system for hepatitis C virus. Nat Protoc (2006) 2.14
Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J Virol (2002) 1.66
Protective effect of rutin on paracetamol- and CCl4-induced hepatotoxicity in rodents. Fitoterapia (2002) 1.65
Viral hepatitis in liver transplantation. Gastroenterology (2012) 1.59
Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res (2003) 1.53
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology (2011) 1.52
(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology (2012) 1.34
Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgaris. Virology (1992) 1.18
Viral infectious disease and natural products with antiviral activity. Drug Discov Ther (2007) 1.14
Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm (Vienna) (1998) 1.06
Inhibition of growth of human immunodeficiency virus in vitro by crude extracts of Chinese medicinal herbs. Antiviral Res (1988) 1.04
Hepatitis C virus and natural compounds: a new antiviral approach? Viruses (2012) 1.03
Quercetin glucosides interact with the intestinal glucose transport pathway. Free Radic Biol Med (1998) 1.03
Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J Viral Hepat (2011) 0.95
Antioxidant activity of prune (Prunus domestica L.) constituents and a new synergist. J Agric Food Chem (2002) 0.91
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action. J Virol (2015) 0.85
In vitro antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against herpes simplex virus and poliovirus. Antiviral Res (1987) 0.84
Antioxidant properties of prunes (Prunus domestica L.) and their constituents. Biofactors (2004) 0.82
Abscisic acid related compounds and lignans in prunes (Prunus domestica L.) and their oxygen radical absorbance capacity (ORAC). J Agric Food Chem (2004) 0.81
In vitro anti-HCV activities of Saxifraga melanocentra and its related polyphenolic compounds. Antivir Chem Chemother (2005) 0.80
Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy. Vaccine (2015) 0.79
A new bipyrrole and some phenolic constituents in prunes (Prunus domestica L.) and their oxygen radical absorbance capacity (ORAC). Biosci Biotechnol Biochem (2004) 0.78
Pan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian Artichoke. J Virol (2015) 0.78
Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system. PLoS One (2013) 0.77